Preemptive temporary right ventricular assist device implantation for severe biventricular heart failure: A case series
Artificial Organs · 2025
DOI: 10.1111/aor.14853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2025. Verfasst von Takuma Miyamoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Heart Failure, Heart-Assist Devices. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Purpose
We sought to investigate the clinical results of preemptive temporary right ventricular assist device (RVAD) placement with left ventricular assist device (LVAD) implantation for anticipated right ventricular failure.
Methods
Patients at risk for right ventricular failure were identified by the heart team. After median sternotomy, Protekduo (LivaNova, London, UK) dual‐stage cannula was inserted from the right internal jugular vein under fluoroscopy guidance, and advanced into the pulmonary artery to the bifurcation of the main pulmonary artery. This was then connected to the venous drainage from the right atrium for cardiopulmonary bypass (CPB). After LVAD implantation, we connected the Protekduo cannula to the RVAD with oxygenator, and weaned CPB.
Results
A total of 17 patients have received BiVAD implantation with this technique. The median age of patients was 55 years [Interquartile range (IQR): 51–63.5] and 94% (16/17) patients were male. 63.6% (7/11) of the patients were INTERMACS profile 1 or 2. Preoperatively, the median pulmonary artery pulsatility index was 4.0 [1.5–4.9] and median right ventricular stroke work index was 454.1 g/m/beat/m 2 [436.5–530.2]. Postoperatively, the oxygenators were removed on median postoperative day (POD) 3.5 [3 – 5]. Patients received mechanical ventilation for a median of 4 days [1.5–12] and RVADs were explanted on median POD 8 [7–19] at bedside with local anesthesia. Median ICU stay was 15 days [11.4–24]. Perioperative complications included delayed sternal closure [54.5% (6/11)], re‐exploration for bleeding [18% (2/11)], acute kidney injury [36% (4/11)], and heparin induced thrombocytopenia [18% (2/11)]. 30‐day mortality was 0% (0/11) and 1 year survival was 85.9%.
Conclusion
Preemptive temporary RVAD implantation strategy for right heart failure post‐LVAD showed acceptable clinical outcomes without any 30‐day mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Department of Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
- Department of Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
- Division of Cardiology, Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Ron Leong, Stefanie Marek-Iannucci, John W Entwistle, Vakhtang Tchantchaleishvili
Zitieren
APA
Miyamoto, T., Rahimov, D., Ahmad, D., Wood, C. T., Leong, R., Marek-Iannucci, S., Brailovsky, Y., Rajapreyar, I., Rame, J. E., Alvarez, R. J., Entwistle, J. W., Tchantchaleishvili, V., & Massey, H. T. (2025). Preemptive temporary right ventricular assist device implantation for severe biventricular heart failure: A case series. Artificial Organs. https://doi.org/10.1111/aor.14853
Vancouver
Miyamoto T, Rahimov D, Ahmad D, Wood CT, Leong R, Marek-Iannucci S, et al. Preemptive temporary right ventricular assist device implantation for severe biventricular heart failure: A case series. Artificial Organs. 2025. doi:10.1111/aor.14853
BibTeX
@article{Miyamoto2025,
author = {Miyamoto, Takuma and Rahimov, Daler and Ahmad, Danial and Wood, Chelsey T and Leong, Ron and Marek-Iannucci, Stefanie and Brailovsky, Yevgeniy and Rajapreyar, Indranee and Rame, J Eduardo and Alvarez, Rene J and Entwistle, John W and Tchantchaleishvili, Vakhtang and Massey, Howard T},
title = {Preemptive temporary right ventricular assist device implantation for severe biventricular heart failure: A case series},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.14853}
}
EUVIMED